<DOC>
	<DOC>NCT02698813</DOC>
	<brief_summary>The overall goal of this study is to evaluate the safety and exploratory efficacy of the injectable filler agent composed of umbilical cord mesenchymal stem cells and hyaluronic acid for the improvement of wrinkles, acne, pitting scar and so on.</brief_summary>
	<brief_title>Safety Study of Filler Agent Composed of Umbilical Cord Mesenchymal Stem Cells and Hyaluronic Acid</brief_title>
	<detailed_description />
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>1. Male or female over 18 years; 2. Have ability to understand and comply with the study requirements, and provide the written informed consent prior to any procedures ; 3. Suitable for the medical history and physical examination like the following preoperative laboratory tests results: complete blood count, coagulation, biochemistry, electrocardiogram, hepatogram and Î²human chorionic gonadotropin (hCG) for women of childbearing age. 1. Patients unable to undergo surgery liposuction with Klein technique as those with severe cardiovascular disease, severe coagulation disorders including thrombophilia and pregnancy; 2. Have history or active dermal diseases, inflammation, or any related disease; 3. Had invasive aesthetic treatments or surgeries history 6 months before the treatments; 4. Had physical or chemical aesthetic treatments 1 months before the study starts; 5. Have a known history of allergic reactions like hypersensitivity to hyaluronic acid; 6. Patients with limited understanding of the procedure or have poor compliance with the study or followup schedule; 7. Pregnant or lactating; 8. Use of drugs; 9. Patients with preoperative results considered inadequate.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>